AstraZeneca Invests $2 Billion to Expand Biologics Manufacturing Footprint in Maryland

AstraZeneca  Maryland Investment: $2 Billion Expansion Brings 2,600 Jobs to Frederick, Gaithersburg

Maryland’s Largest Private Capital Investment: AstraZeneca  to Expand Manufacturing with $2 Billion Commitment Governor Wes Moore announced on November 21, 2025, that AstraZeneca, a global biopharmaceutical company, will invest $2 billion to expand its manufacturing footprint across Maryland. The investment represents the largest private capital investment in the state in the past decade and will create approximately 2,600 jobs across Frederick …

AstraZeneca Invests $2 Billion to Expand Biologics Manufacturing Footprint in Maryland

The pharmaceutical giant will be nearly doubling biologics production in Frederick and build a new clinical supply facility in Gaithersburg, projects that will create thousands of jobs, enhance US supply chain resilience, and advance its growing rare disease portfolio.